Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Lyme Disease - Overview
Lyme Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Lyme Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Lyme Disease - Companies Involved in Therapeutics Development
Abzyme Therapeutics LLC
Agile Sciences Inc
Artes Biotechnology GmbH
Cortene Inc
Flightpath BioSciences Inc
Inovio Pharmaceuticals Inc
Ixodes AG
L2 Diagnostics LLC
NovoBiotic Pharmaceuticals LLC
Reven Pharmaceuticals Inc
Valneva SE
Lyme Disease - Drug Profiles
azithromycin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
azlocillin sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bispecific Monoclol Antibody to Inhibit CRASP1 for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CT-38 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
desloratadine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
disulfiram - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Inhibit OspA for Lyme Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lyme disease vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
lyme disease vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Lyme Disease - Dormant Projects
Lyme Disease - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Lyme Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Lyme Disease, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Lyme Disease - Pipeline by Abzyme Therapeutics LLC, H2 2020
Lyme Disease - Pipeline by Agile Sciences Inc, H2 2020
Lyme Disease - Pipeline by Artes Biotechnology GmbH, H2 2020
Lyme Disease - Pipeline by Cortene Inc, H2 2020
Lyme Disease - Pipeline by Flightpath BioSciences Inc, H2 2020
Lyme Disease - Pipeline by Inovio Pharmaceuticals Inc, H2 2020
Lyme Disease - Pipeline by Ixodes AG, H2 2020
Lyme Disease - Pipeline by L2 Diagnostics LLC, H2 2020
Lyme Disease - Pipeline by NovoBiotic Pharmaceuticals LLC, H2 2020
Lyme Disease - Pipeline by Reven Pharmaceuticals Inc, H2 2020
Lyme Disease - Pipeline by Valneva SE, H2 2020
Lyme Disease - Dormant Projects, H2 2020